logo

DRIO

DarioHealth·NASDAQ
--
--(--)
--
--(--)
Signals Analysis
Bullish signal 0
Bearish signal 2
EPS Below Expectations
Revenue Below Expectations

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About DRIO

Dariohealth Corp.

A leading developer of medical devices and solutions to monitor blood glucose using smart phones

Healthcare Equipment and Supplies
08/11/2011
03/04/2016
NASDAQ Stock Exchange
196
12-31
Common stock
322 W. 57th St. #33B, New York, New York 10019
--
DarioHealth Corp. was incorporated on August 11, 2011 as a Delaware corporation. As a leading global digital health company, its core mission is to drive behavioral changes that drive better health. The company focuses on user engagement and provides personalized solutions through a self-developed whole-person health platform. Originally rooted in the direct-to-consumer (D2C) market and used as an innovation lab, it has expanded into the business-to-business (BB) segment, which now accounts for three-quarters of its revenue. Serving four key market segments, its clients include medium and large employers, health plans and global pharmaceutical companies. In 2024, the company has 53 employer clients, including the world's top technology companies and major employers in the United States, and the solution brings a good return on investment. Acquiring companies like Twill further strengthens its capabilities in chronic disease and mental health services.

Company Financials

EPS

DRIO has released its 2025 Q3 earnings. EPS was reported at -2.96, versus the expected -0.19, missing expectations. The chart below visualizes how DRIO has performed over recent quarters, highlighting trends in earnings surprises.

Revenue & Expenses

DRIO has released its 2025 Q3 earnings report, with revenue of 5.01M, reflecting a YoY change of -32.55%, and net profit of -10.47M, showing a YoY change of 15.12%. The Sankey diagram below clearly presents DRIO's revenue sources and cost distribution.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime

No Data